Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

3.760

-0.010 (-0.27%)

At close: Aug 28, 2026, 4:00 PM EDT

3.770

+0.010 (0.27%)

After-hours: Aug 28, 2026, 4:27 PM EDT

Neuphoria Therapeutics Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	-0.01	15.65	-	-	0.18	-
Other Revenue	-	-	-	-	3.99	0.7
Revenue	-0.01	15.65	-	-	4.17	0.7
Revenue Growth	-	-	-	-	499.60%	-66.32%
Cost of Revenue	-	-	-	-	11.02	4.32
Gross Profit	-0.01	15.65	-	-	-6.85	-3.62
Selling, General & Admin	7.74	7.77	8.47	8.91	5.28	4.23
Research & Development	6.91	8.71	9.32	12.65	-	-
Other Operating Expenses	-	-	-	-	-0	-0.15
Operating Expenses	14.65	16.48	17.8	21.56	5.27	4.08
Operating Income	-14.66	-0.83	-17.8	-21.56	-12.12	-7.7
Interest Expense	-	-	-	-	-0.02	-1.07
Interest & Investment Income	0.58	0.17	0.22	0.32	0.01	0
Currency Exchange Gain (Loss)	-1.43	-0.41	-0.21	0.31	0.25	0.81
Other Non Operating Income (Expenses)	-1.26	-	-	-0.59	-2.59	-1.22
EBT Excluding Unusual Items	-16.76	-1.08	-17.79	-21.52	-14.48	-9.18
Merger & Restructuring Charges	-1.28	-	-	-	-	-
Gain (Loss) on Sale of Investments	0.24	0.24	2.21	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-0	-0.02
Other Unusual Items	-	-	-	-	-0.65	2.54
Pretax Income	-17.8	-0.84	-15.58	-21.52	-15.12	-6.66
Income Tax Expense	-0.37	-0.47	-0.09	-0.14	-0.13	-0.14
Earnings From Continuing Operations	-17.43	-0.37	-15.49	-21.38	-14.99	-6.52
Net Income	-17.43	-0.37	-15.49	-21.38	-14.99	-6.52
Net Income to Common	-17.43	-0.37	-15.49	-21.38	-14.99	-6.52
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	4	2	1	1,469	1,353	780
Shares Outstanding (Diluted)	4	2	1	1,469	1,353	780
Shares Change	161.08%	95.01%	-99.94%	8.53%	73.52%	43.14%
EPS (Basic)	-4.95	-0.23	-18.62	-0.01	-0.01	-0.01
EPS (Diluted)	-4.95	-0.23	-18.62	-0.01	-0.01	-0.01
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-17.15	0.08	-14.68	-14.64	-14.99	-5.65
Free Cash Flow Per Share	-4.87	0.05	-17.64	-0.01	-0.01	-0.01
Gross Margin	-	100.00%	-	-	-164.21%	-
Operating Margin	-	-5.30%	-	-	-290.62%	-1107.29%
Profit Margin	-	-2.36%	-	-	-359.34%	-937.11%
Free Cash Flow Margin	-	0.49%	-	-	-359.30%	-812.46%
EBITDA	-14	-0.17	-17.13	-20.9	-11.49	-7
EBITDA Margin	-	-1.06%	-	-	-275.36%	-
D&A For EBITDA	0.66	0.66	0.66	0.66	0.64	0.7
EBIT	-14.66	-0.83	-17.8	-21.56	-12.12	-7.7
EBIT Margin	-	-5.30%	-	-	-290.62%	-

SEC Filings: 10-K · 10-Q